Banner
Home Fascicolo n.3/2003 Bibliografia
Bibliografia
Percorso reumatologico
pubblicato nel Maggio - Giugno 2003 ne Il Fisioterapista - fascicolo n.3

Bibliografia

  1. McCraebf, Shouls J, Dieppe P et al. The eterogeneity of osteoartrhritis of the Knee. Br J Rheumatol 1987; 26: A25.

  2. Ciocci A, Mauceri MT. Epidemiologia e costi sociali delle malattie reumatiche: dati recenti. Reumatismo 1994; 46: 14-20.

  3. Hochberg MC. Epidemiology of OA: current concepts and new insights. J Rheum 1991; 18 (Suppl 27): 4-6.

  4. Altman RD. Classification of disease: osteoarthritis. Sem Arthritis Rhem 1991; 20 (Suppl 2): 40-7.

  5. Loyau G, Groit M, Bontoux D. Définition et critères diagnostiques de l’arthrose. Rev Rhum 1990; 57: 58-98.

  6. Moskowitz RW, ed. OA. Rheum Dis Clin N Amer 1993; 19: 523-763.

  7. Sokolof L et al. OA. Clin Rheum Dis 1995; 11: 175-449.

  8. Wright V. Osteoarthritis: diagnosis is not as simple as it seems. Br Med J 1989; 299: 1476-7.

  9. Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol 1991; 18 (Suppl 27): 10-2.

  10. Schumacher HR Jr. Synovial inflammation, crystals and osteoarthritis. J Rheumatol Suppl 1995; 43: 101-3.

  11. Alexander CJ. Osteoarthritis: a review of old myths and current concepts. Skeletal Radiol 1990; 19(5): 327-33.

  12. Marcolongo R. Il ruolo e i compiti del reumatologo nella lotta contro le malattie reumatiche. Reumatologia Oggi 1991; 10: 4-5.

Bibliografia di inserto Percorso reumatologico

  1. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1, 799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000; 43: 378-85.

  2. Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000; 27: 1020-7.

  3. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316: 333-8.

  4. Griffin MR, Ray WA, Schaffner W. Nonsteroidal antiinflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-63.

  5. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.

  6. Garell S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore) 1984; 63: 165-81.

  7. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walzer F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 2: 519-22.

  8. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357 (9252): 251-6.

  9. Rovati LC. The clinical profile of glucosamine sulphate as a selective symptom modifying drug in osteoarthritis: current data and perspectives. Osteoarthritis Cartilage 1997; 5 (Suppl A): 72.